HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

Linden Thomas Advisory Services, LLC's Holding History (CIK: 0001965702)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 34,803 Value ($000) $2,342 Avg Close $67.27 Range $61.23 - $76.30
Q3 2025
Shares 35,244 Value ($000) $2,585 Avg Close $66.43 Range $51.78 - $79.50
Q2 2025
Shares 35,235 Value ($000) $1,833 Avg Close $56.90 Range $47.50 - $70.51
Q1 2025
Shares 35,881 Value ($000) $2,290 Avg Close $58.09 Range $47.52 - $66.00
Q4 2024
Shares 34,991 Value ($000) $1,673 Avg Close $51.28 Range $42.01 - $62.13
Q3 2024
Shares 35,340 Value ($000) $2,023 Avg Close $57.33 Range $50.68 - $65.53
Q2 2024
Shares 35,328 Value ($000) $1,850 Avg Close $43.86 Range $37.73 - $53.00
Q1 2024
Shares 42,497 Value ($000) $1,729 Avg Close $37.49 Range $33.15 - $42.64
Q4 2023
Shares 42,457 Value ($000) $1,569 Avg Close $37.66 Range $32.83 - $42.82
Q3 2023
Shares 42,450 Value ($000) $1,622 Avg Close $40.96 Range $35.71 - $45.00
Q2 2023
Shares 37,324 Value ($000) $1,346 Avg Close $34.12 Range $29.85 - $38.80
Q1 2023
Shares 37,143 Value ($000) $1,418 Avg Close $46.91 Range $32.83 - $57.00
Q4 2022
Shares 36,249 Value ($000) $2,063 Avg Close $51.20 Range $39.17 - $59.46